Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “Nektar Therapeutics”

423 pharma patents match "Nektar Therapeutics" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 423
Index total 30,257
Page 9 / 18

Quick answer

This filtered view shows 423 pharmaceutical patents matching "Nektar Therapeutics" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

423 results for “Nektar Therapeutics” · 30,257 patents in full index Clear search

  1. US 8895553

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Nov 25, 2014 · Expires Nov 20, 2034

    granted
  2. US 8889831

    Unit dosage forms of pharmaceutical compositions comprising a polymer-factor VIII polypeptide conjugate

    Nektar Therapeutics · Granted Nov 18, 2014 · Expires Nov 13, 2034

    granted
  3. US 8865149

    Polymeric reagents comprising a ketone or a related functional group

    Nektar Therapeutics · Granted Oct 21, 2014 · Expires Oct 16, 2034

    granted
  4. US 8853325

    Water-soluble polymer alkanals

    Nektar Therapeutics · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  5. US 8853247

    Oligomer-nitroimidazole anti-infective conjugates

    Nektar Therapeutics · Granted Oct 7, 2014 · Expires Oct 2, 2034

    granted
  6. US 8835599

    Segmented degradable polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  7. US 8835556

    Hydrolytically stable maleimide-terminated polymers

    Nektar Therapeutics · Granted Sep 16, 2014 · Expires Sep 11, 2034

    granted
  8. US 8828359

    Particulate materials

    Nektar Therapeutics · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  9. US 8829043

    Oligome-cannabinoid conjugates

    Nektar Therapeutics · Granted Sep 9, 2014 · Expires Sep 4, 2034

    granted
  10. US 8816077

    Oligomer-protein tyrosine kinase inhibitor conjugates

    Nektar Therapeutics · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  11. US 8816002

    Method involving 1-benzotriazolyl carbonate esters of poly(ethylene glycol)

    Nektar Therapeutics · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  12. US 8815227

    Hydroxyapatite-targeting multiarm polymers and conjugates made therefrom

    Nektar Therapeutics · Granted Aug 26, 2014 · Expires Aug 21, 2034

    granted
  13. US 8809489

    Methods for preparing polymeric reagents and compositions of polymeric reagents

    Nektar Therapeutics · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  14. US 8809453

    Branched polymers

    Nektar Therapeutics · Granted Aug 19, 2014 · Expires Aug 14, 2034

    granted
  15. US 8796248

    Oligomer-corticosteroid conjugates

    Nektar Therapeutics · Granted Aug 5, 2014 · Expires Jul 31, 2034

    granted
  16. US 8785661

    Oligome-containing pyrrolidine compounds

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  17. US 8784791

    Method for preparing water-soluble polymer derivatives bearing an N-succinimidyl ester

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  18. US 8784849

    Hydroxyapatite-targeting poly(ethylene glycol) and related polymers

    Nektar Therapeutics · Granted Jul 22, 2014 · Expires Jul 17, 2034

    granted
  19. US 8778898

    Oligomer conjugates of heteropentacyclic nucleosides

    Nektar Therapeutics · Granted Jul 15, 2014 · Expires Jul 10, 2034

    granted
  20. US 8771662

    Multi-arm polymer prodrugs

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  21. US 8772479

    Oligomer-containing substituted aromatic triazine compounds

    Nektar Therapeutics · Granted Jul 8, 2014 · Expires Jul 3, 2034

    granted
  22. US 8765883

    Stabilized polymeric thiol reagents

    Nektar Therapeutics · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  23. US 8765111

    N-maleimidyl polymer derivatives

    Nektar Therapeutics · Granted Jul 1, 2014 · Expires Jun 26, 2034

    granted
  24. US 8748648

    Oligomer-calcium channel blocker conjugates

    Nektar Therapeutics · Granted Jun 10, 2014 · Expires Jun 5, 2034

    granted